Showing results (111-120 of 1,193) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|May 1, 2025
LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered BreathingShoichiro Yatsu, Anna Woo, Christian M Horvath, et al.
JACC. Heart Failure|September 24, 2025
Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac DevicesPedro Marques, Christoforos K Travlos, Paula Matias, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
JACC. Heart Failure|October 11, 2025
Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart TransplantationLauren K Truby, Yasbanoo Moayedi, Marisa Signorile, et al.
JACC. Heart Failure|October 11, 2025
Long-Term Outcomes in Women With a History of Peripartum CardiomyopathyOrtal Tuvali, Rafael Kuperstein, Donna R Zwas, et al.
JACC. Heart Failure|July 27, 2025
Expanded Definition of Worsening Heart Failure: Impact on Clinical Outcomes and Quality-of-Life AssessmentRichard S Chaudhary, Syed M D Hussain, Yong-Shi Wang, et al.
JACC. Heart Failure|September 3, 2013
Aortic root remodeling and risk of heart failure in the Framingham Heart studyCarolyn S P Lam, Philimon Gona, Martin G Larson, et al.
JACC. Heart Failure|October 6, 2014
Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fractionDaniel H Katz, Jacob A Burns, Frank G Aguilar, et al.
JACC. Heart Failure|October 6, 2014
Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION studyChristof Kolb, Marcio Sturmer, Peter Sick, et al.
JACC. Heart Failure|October 13, 2014
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFTDennis M McNamara, Anne L Taylor, S William Tam, et al.
Pageof 120